Journal Club CLEAR SYNERGY OASIS 9, A Randomized Trial of Colchicine and Spironolactone in Acute Myocardial Infarction with Sanjit S. Jolly with Dr. Sanjit S. Jolly Patients experiencing myocardial infarction (MI) remain at high risk of…ideazioNovember 16, 2024
Journal Club OCT-Imaging Predictors of Clinical Outcomes, the ILUMIEN IV: Optimal PCI with Ziad Ali with Ziad A Ali MD DPhil Each week, we present a journal club in which…ideazioNovember 8, 2024
Journal Club Invasive Treatment Strategy for Older Patients with Myocardial Infarction (the SENIOR-RITA trial) with Vijay Kunadian In older adults with NSTEMI, an invasive strategy did not result in a significantly lower…ideazioNovember 2, 2024
Journal Club Revascularization for Ischemic Cardiomyopathy with Divaka Perera with Dr. Divaka Perera Complete revascularization of coronary artery disease has been linked to improved…ideazioOctober 26, 2024
Journal Club Reconsidering the Direction of Coronary Revascularization Trials with Gregg W. Stone PCI vs. CABG in Women and Under-represented Minority Patients Assessed with a Novel Primary Endpoint:…ideazioOctober 11, 2024
Journal Club Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease (the EPIC-CAD trial) with Duk-Woo Park In patients with atrial fibrillation and stable coronary artery disease, edoxaban monotherapy led to a…ideazioOctober 5, 2024
Journal Club Transcatheter Repair vs. Mitral Valve Surgery for Secondary Mitral Regurgitation (the MATTERHORN trial) with Stephan Baldus ideazioSeptember 28, 2024
Journal Club Transcatheter Valve Repair in Heart Failure with Moderate to Severe Regurgitation (the RESHAPE-HF2 trial) with Stefan Anker Among patients with heart failure with moderate to severe functional mitral regurgitation who received medical…ideazioSeptember 20, 2024
Journal Club Impact of Cerebral Embolic Protection Devices on Disabling Stroke after Transcatheter Aortic Valve Replacement: Updated Results from the STS/ACC TVT Registry with Neel Butala Cerebral embolic protection devices (EPDs) were developed to mitigate the risk of stroke during transcatheter…ideazioSeptember 6, 2024
Journal Club ORBITA-STAR trial and the ORBITA II Symptoms Analysis with Rasha Al-Lamee, Chris Rajkumar, and Florentina Simader In stable coronary artery disease, 30% to 60% of patients remain symptomatic despite successful revascularization.…ideazioAugust 16, 2024